|
SLC25A36 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.76750000378124E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.44260000000263E-05 |
| Normal-vs-Stage2 |
2.195700E-02 |
| Normal-vs-Stage3 |
4.97289999956685E-07 |
| Normal-vs-Stage4 |
4.15819999544098E-08 |
| Stage1-vs-Stage2 |
8.286200E-01 |
| Stage1-vs-Stage3 |
6.972100E-02 |
| Stage1-vs-Stage4 |
2.040100E-02 |
| Stage2-vs-Stage3 |
4.088600E-01 |
| Stage2-vs-Stage4 |
2.102800E-01 |
| Stage3-vs-Stage4 |
5.193000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.25130000092366E-08 |
| Normal-vs-AfricanAmerican |
3.758000E-02 |
| Normal-vs-Asian |
4.874600E-01 |
| Caucasian-vs-AfricanAmerican |
1.974630E-01 |
| Caucasian-vs-Asian |
3.419800E-01 |
| AfricanAmerican-vs-Asian |
6.672400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.47809999584814E-08 |
| Normal-vs-Female |
9.669499999998E-05 |
| Male-vs-Female |
3.117600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.973600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.539900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.12159947995849E-10 |
| Normal-vs-Age(81-100Yrs) |
2.98549999999675E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.117000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.661500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.505800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.392300E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.577800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.891600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.540200E-01 |
| Normal-vs-Grade 2 |
2.397500E-03 |
| Normal-vs-Grade 3 |
1.04509999543367E-08 |
| Normal-vs-Grade 4 |
3.50329998344279E-09 |
| Grade 1-vs-Grade 2 |
2.327800E-01 |
| Grade 1-vs-Grade 3 |
3.584100E-03 |
| Grade 1-vs-Grade 4 |
1.723060E-03 |
| Grade 2-vs-Grade 3 |
7.083400E-03 |
| Grade 2-vs-Grade 4 |
8.367900E-04 |
| Grade 3-vs-Grade 4 |
1.276570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.559020E-04 |
| Normal-vs-ccB subtype |
6.41789999999975E-05 |
| ccA subtype-vs-ccB subtype |
7.864800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88545999999512E-05 |
| Normal-vs-N1 |
3.97069999999999E-05 |
| N0-vs-N1 |
6.906100E-02 |
|
|
